These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15611244)

  • 1. Hyperthermia enhances CD95-ligand gene expression in T lymphocytes.
    Cippitelli M; Fionda C; Di Bona D; Piccoli M; Frati L; Santoni A
    J Immunol; 2005 Jan; 174(1):223-32. PubMed ID: 15611244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.
    Villalba M; Kasibhatla S; Genestier L; Mahboubi A; Green DR; Altman A
    J Immunol; 1999 Dec; 163(11):5813-9. PubMed ID: 10570264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
    Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.
    Villunger A; Ghaffari-Tabrizi N; Tinhofer I; Krumböck N; Bauer B; Schneider T; Kasibhatla S; Greil R; Baier-Bitterlich G; Uberall F; Green DR; Baier G
    Eur J Immunol; 1999 Nov; 29(11):3549-61. PubMed ID: 10556809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells.
    Chow WA; Fang JJ; Yee JK
    J Immunol; 2000 Apr; 164(7):3512-8. PubMed ID: 10725705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.
    Li-Weber M; Laur O; Hekele A; Coy J; Walczak H; Krammer PH
    Eur J Immunol; 1998 Aug; 28(8):2373-83. PubMed ID: 9710215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation.
    Li-Weber M; Laur O; Krammer PH
    Eur J Immunol; 1999 Sep; 29(9):3017-27. PubMed ID: 10508276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB.
    Li-Weber M; Laur O; Dern K; Krammer PH
    Eur J Immunol; 2000 Feb; 30(2):661-70. PubMed ID: 10671224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma.
    Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Ju ST
    J Immunol; 1998 Oct; 161(7):3469-73. PubMed ID: 9759866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression.
    Pardo J; Buferne M; Martínez-Lorenzo MJ; Naval J; Schmitt-Verhulst AM; Boyer C; Anel A
    Int Immunol; 2003 Dec; 15(12):1441-50. PubMed ID: 14645153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
    Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
    Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappa B-dependent Fas ligand expression.
    Hsu SC; Gavrilin MA; Lee HH; Wu CC; Han SH; Lai MZ
    Eur J Immunol; 1999 Sep; 29(9):2948-56. PubMed ID: 10508269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability.
    Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Gómez-Hernández A; Arribas A; Ortega L; Tuñón J; Egido J
    Stroke; 2004 Feb; 35(2):458-63. PubMed ID: 14739407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of FasL by NF-kappaB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells.
    Harwood FG; Kasibhatla S; Petak I; Vernes R; Green DR; Houghton JA
    J Biol Chem; 2000 Apr; 275(14):10023-9. PubMed ID: 10744679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes.
    Bodor J; Bodorova J; Bare C; Hodge DL; Young HA; Gress RE
    Eur J Immunol; 2002 Jan; 32(1):203-12. PubMed ID: 11754361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
    Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
    Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.
    Kasibhatla S; Genestier L; Green DR
    J Biol Chem; 1999 Jan; 274(2):987-92. PubMed ID: 9873041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.